Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × UNKNOWN × Lenalidomide × Clear all

Phase

Status

Sponsor Class

OTHER 52 NETWORK 2 INDUSTRY 2 UNKNOWN 1 OTHER_GOV 1 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hodgkin Disease 1

Interventions

Capecitabine 14 Paclitaxel 12 Oxaliplatin 8 Carboplatin 8 apatinib 7 S 1 (combination) 7 pyrotinib 6 Cisplatin 6 sintilimab 5 camrelizumab 5 anlotinib 5 Epirubicin 5 nedaplatin 4 Vinorelbine 4 Radiotherapy 4 Irinotecan 4 Etoposide 4 Drug Therapy 4 Docetaxel 4 Bevacizumab 4 130-nm albumin-bound paclitaxel 4 toripalimab 3 Trastuzumab 3 Temozolomide 3 Radiosurgery 3 Neoadjuvant Therapy 3 HMPL-013 3 Gemcitabine 3 Fulvestrant 3 Chemotherapy, Adjuvant 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01412307 2015-08-11

LEBEN

GiovanniPascale

Phase 1/2 Unknown

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡